← Leaderboards

Costas Andreas Lyssiotis

University Of Michigan At Ann Arbor

Google Scholar ↗PubMed ↗ORCID ↗

$8,196,905

Attributed

$10,662,017

Total exposure

5

Grants

4

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY2020–25

$2.5M$1.9M$1.3M$625K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$10,662,017 · 5

By mechanism

R01$3,903,810 · 2

U01$3,286,816 · 1

R37$2,195,997 · 1

P01$1,275,394 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cells”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Evan Z Macosko · Broad Institute, Inc.$33,096,828
James Dale Berry · Brigham And Women'S Hospital$30,122,905
Hanjoon Ryu$28,519,898
Eric C Palm · Florida State University$26,502,247

Research focus

CellsMalignant NeoplasmsMetabolicPathway InteractionsMetabolomicsMetabolic PathwayPropertyResearch ProposalsInsightMetabolismPharmaceutical PreparationsIn VivoCancer CellFibroblastsMalignant Neoplasm Of PancreasTumorMediatingMouse ModelPancreatic NeoplasmPancreatic Cancer CellsPancreatic Ductal AdenocarcinomaImpairmentEffective TherapyIncidence

Grant awards (25)

Fibroblast orchestration of the immune response in pancreatic cancer$826,873

U01 · FY2025 · CA

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$361,018

R37 · FY2025 · CA · contact PI

Fibroblast orchestration of the immune response in pancreatic cancer$786,440

U01 · FY2024 · CA

Stromal metabolism promotes therapeutic resistance in pancreatic cancer$379,104

R01 · FY2024 · CA · contact PI

Targeting metabolic stress to induce pancreatic tumor cell death$370,329

R01 · FY2024 · CA · contact PI

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$352,808

R37 · FY2024 · CA · contact PI

Metabolomics Core$241,724

P01 · FY2024 · HL · contact PI

Fibroblast orchestration of the immune response in pancreatic cancer$829,209

U01 · FY2023 · CA

Stromal metabolism promotes therapeutic resistance in pancreatic cancer$392,124

R01 · FY2023 · CA · contact PI

Targeting metabolic stress to induce pancreatic tumor cell death$383,140

R01 · FY2023 · CA · contact PI

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$364,847

R37 · FY2023 · CA · contact PI

Metabolomics Core$251,500

P01 · FY2023 · HL · contact PI

Fibroblast orchestration of the immune response in pancreatic cancer$844,294

U01 · FY2022 · CA

Stromal metabolism promotes therapeutic resistance in pancreatic cancer$401,168

R01 · FY2022 · CA · contact PI

Targeting metabolic stress to induce pancreatic tumor cell death$384,227

R01 · FY2022 · CA · contact PI

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$373,469

R37 · FY2022 · CA · contact PI

Metabolomics Core$256,202

P01 · FY2022 · HL · contact PI

Stromal metabolism promotes therapeutic resistance in pancreatic cancer$402,177

R01 · FY2021 · CA · contact PI

Targeting metabolic stress to induce pancreatic tumor cell death$393,143

R01 · FY2021 · CA · contact PI

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$374,610

R37 · FY2021 · CA · contact PI

Metabolomics Core$260,768

P01 · FY2021 · HL · contact PI

Targeting metabolic stress to induce pancreatic tumor cell death$401,714

R01 · FY2020 · CA · contact PI

Stromal metabolism promotes therapeutic resistance in pancreatic cancer$396,684

R01 · FY2020 · CA · contact PI

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer$369,245

R37 · FY2020 · CA · contact PI

Metabolomics Core$265,200

P01 · FY2020 · HL · contact PI